Answers are grounded in this paper and cite their sources.
Highlights the rare complication of aorto-RV fistula after TAVR in a patient with wild-type transthyretin cardiac amyloidosis, suggesting a need for amyloidosis screening in TAVR patients.
<ns3:p>Aortic to right ventricular fistula formation after transcatheter aortic valve replacement (TAVR) is a rare complication. We describe the first case of an aorto-RV fistula after TAVR, conservatively managed, in a patient with concomitant aortic stenosis and wild-type transthyretin cardiac amyloidosis. Given that the underlying pathology may have implications, transthyretin cardiac amyloidosis screening in patients undergoing TAVR is warranted.</ns3:p>
No takes yet. Share an insight, caveat, or question.
García-Gómez et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: